| Shaun Stuart Potier, DPT | |
|
3 Medical Plz, Mountain Home, AR 72653-2918 | |
| (870) 424-3400 | |
| (870) 424-4121 |
| Full Name | Shaun Stuart Potier |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 3 Years |
| Location | 3 Medical Plz, Mountain Home, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255007407 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT5002 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Arkansas Speech Services Llc | 9133545759 | 7 |
| Regional Orthopaedic Health Care | 1052446051 | 6 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company dedicated to developing and commercializing first-in-class oncology therapeutics, today announced that it has been issued a United States patent (No. 8,314,100), titled "1-[6,7-substituted alkoxyquinoxalinyl) aminocarbonyl]-4-(hetero) arylpiperazine derivatives."
The prevalence of nonrefractive visual impairment (not due to need for glasses) in the U.S. has increased significantly in recent years, which may be partly related to a higher prevalence of diabetes, an associated risk factor, according to a study in the December 12 issue of JAMA.
OHSU physicians and researchers are developing what they hope will be the first permanent total artificial heart, which could provide the approximately 75,000 Americans who die of heart failure every year another chance at life.
A next-generation brain implant currently in clinical use for treating refractory epilepsy – to help prevent symptoms including seizures – does not induce changes to patients' personalities or self-perceptions, a new study of patient experiences shows.
› Verified 6 days ago
| Provider Name | Regional Orthopaedic Health Care |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1568477123 PECOS PAC ID: 1052446051 Enrollment ID: O20100316000681 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company dedicated to developing and commercializing first-in-class oncology therapeutics, today announced that it has been issued a United States patent (No. 8,314,100), titled "1-[6,7-substituted alkoxyquinoxalinyl) aminocarbonyl]-4-(hetero) arylpiperazine derivatives."
The prevalence of nonrefractive visual impairment (not due to need for glasses) in the U.S. has increased significantly in recent years, which may be partly related to a higher prevalence of diabetes, an associated risk factor, according to a study in the December 12 issue of JAMA.
OHSU physicians and researchers are developing what they hope will be the first permanent total artificial heart, which could provide the approximately 75,000 Americans who die of heart failure every year another chance at life.
A next-generation brain implant currently in clinical use for treating refractory epilepsy – to help prevent symptoms including seizures – does not induce changes to patients' personalities or self-perceptions, a new study of patient experiences shows.
› Verified 6 days ago
| Provider Name | North Arkansas Speech Services Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1649880774 PECOS PAC ID: 9133545759 Enrollment ID: O20200813001537 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company dedicated to developing and commercializing first-in-class oncology therapeutics, today announced that it has been issued a United States patent (No. 8,314,100), titled "1-[6,7-substituted alkoxyquinoxalinyl) aminocarbonyl]-4-(hetero) arylpiperazine derivatives."
The prevalence of nonrefractive visual impairment (not due to need for glasses) in the U.S. has increased significantly in recent years, which may be partly related to a higher prevalence of diabetes, an associated risk factor, according to a study in the December 12 issue of JAMA.
OHSU physicians and researchers are developing what they hope will be the first permanent total artificial heart, which could provide the approximately 75,000 Americans who die of heart failure every year another chance at life.
A next-generation brain implant currently in clinical use for treating refractory epilepsy – to help prevent symptoms including seizures – does not induce changes to patients' personalities or self-perceptions, a new study of patient experiences shows.
› Verified 6 days ago
| Provider Name | Barnhill Therapy Services, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1255088381 PECOS PAC ID: 8921488024 Enrollment ID: O20220707001075 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company dedicated to developing and commercializing first-in-class oncology therapeutics, today announced that it has been issued a United States patent (No. 8,314,100), titled "1-[6,7-substituted alkoxyquinoxalinyl) aminocarbonyl]-4-(hetero) arylpiperazine derivatives."
The prevalence of nonrefractive visual impairment (not due to need for glasses) in the U.S. has increased significantly in recent years, which may be partly related to a higher prevalence of diabetes, an associated risk factor, according to a study in the December 12 issue of JAMA.
OHSU physicians and researchers are developing what they hope will be the first permanent total artificial heart, which could provide the approximately 75,000 Americans who die of heart failure every year another chance at life.
A next-generation brain implant currently in clinical use for treating refractory epilepsy – to help prevent symptoms including seizures – does not induce changes to patients' personalities or self-perceptions, a new study of patient experiences shows.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shaun Stuart Potier, DPT 3 Medical Plz, Mountain Home, AR 72653-2918 Ph: (870) 424-3400 | Shaun Stuart Potier, DPT 3 Medical Plz, Mountain Home, AR 72653-2918 Ph: (870) 424-3400 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company dedicated to developing and commercializing first-in-class oncology therapeutics, today announced that it has been issued a United States patent (No. 8,314,100), titled "1-[6,7-substituted alkoxyquinoxalinyl) aminocarbonyl]-4-(hetero) arylpiperazine derivatives."
The prevalence of nonrefractive visual impairment (not due to need for glasses) in the U.S. has increased significantly in recent years, which may be partly related to a higher prevalence of diabetes, an associated risk factor, according to a study in the December 12 issue of JAMA.
OHSU physicians and researchers are developing what they hope will be the first permanent total artificial heart, which could provide the approximately 75,000 Americans who die of heart failure every year another chance at life.
A next-generation brain implant currently in clinical use for treating refractory epilepsy – to help prevent symptoms including seizures – does not induce changes to patients' personalities or self-perceptions, a new study of patient experiences shows.
› Verified 6 days ago
Joyce Marie Yarborough, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 715 W 6th St, Mountain Home, AR 72653 Phone: 870-425-6868 | |
Glenn W Carter, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 413 Colewood Dr, Mountain Home, AR 72653 Phone: 870-425-8558 | |
Dr. Kimberly Eve Kroeze, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3 Medical Plz, Mountain Home, AR 72653 Phone: 807-424-3400 | |
Ozark Therapy, Inc. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 636 Old Tracy Rd, Mountain Home, AR 72653 Phone: 870-424-5747 | |
Ms. Kristi Varnado Steelman, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 636 Old Tracy Rd, Mountain Home, AR 72653 Phone: 870-424-5747 | |
Matthew D Brandon, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3 Medical Plz, Mountain Home, AR 72653 Phone: 870-424-3400 Fax: 870-424-4121 | |
Mr. Rowdy Kelly, P.T., COMT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 200 N College St, Mountain Home, AR 72653 Phone: 870-424-4550 Fax: 870-424-4558 |